Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Esther Broekman

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|March 27, 2025
[Help with nibs and mabs: targeted cancer therapies for non-oncologists]Matthijs Plas, K Esther Broekman, Thijs H Oude Munnink, et al.
Current Opinion in Oncology|October 20, 2021
State of the art and future directions in the systemic treatment of medullary thyroid cancerEline C Jager, K Esther Broekman, Schelto Kruijff, et al.
Gynecologic Oncology|June 1, 2022
End-of-life care for patients with advanced ovarian cancer in the Netherlands: A retrospective registry-based analysisK Esther Broekman, Maaike A van der Aa, Hans W Nijman, et al.
Journal of Geriatric Oncology|October 8, 2023
Representation of older patients in the safety analysis of protein kinase inhibitor registration studiesEmma van Kampen, Mark T J van Bussel, Thijs H Oude Munnink, et al.
BMJ Open|November 10, 2025
Views of European Union medicine regulators and healthcare professionals on the approved versus prescribed dose of protein kinase inhibitors: an interview studyMargot Brinkhof, Sieta T de Vries, Peter G M Mol, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 18, 2024
[A rapidly enlarging neck mass]J F Lin, Thera P Links, K Esther Broekman, et al.
Investigational New Drugs|March 9, 2020
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancerK Esther Broekman, Marieke A J Hof, Daan J Touw, et al.
BMJ Open|November 9, 2024
Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group studyChristine C van Hattem, Amos J de Jong, Jolien S de Groot, et al.
Drugs & Aging|December 20, 2023
Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 PatientsRoos F Bleckman, K Esther Broekman, Evelyne Roets, et al.
Clinical Pharmacokinetics|July 16, 2024
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma CohortMarinda Meertens, Eline L Giraud, Maud B A van der Kleij, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|March 27, 2025
[Help with nibs and mabs: targeted cancer therapies for non-oncologists]Matthijs Plas, K Esther Broekman, Thijs H Oude Munnink, et al.
Current Opinion in Oncology|October 20, 2021
State of the art and future directions in the systemic treatment of medullary thyroid cancerEline C Jager, K Esther Broekman, Schelto Kruijff, et al.
Gynecologic Oncology|June 1, 2022
End-of-life care for patients with advanced ovarian cancer in the Netherlands: A retrospective registry-based analysisK Esther Broekman, Maaike A van der Aa, Hans W Nijman, et al.
Journal of Geriatric Oncology|October 8, 2023
Representation of older patients in the safety analysis of protein kinase inhibitor registration studiesEmma van Kampen, Mark T J van Bussel, Thijs H Oude Munnink, et al.
BMJ Open|November 10, 2025
Views of European Union medicine regulators and healthcare professionals on the approved versus prescribed dose of protein kinase inhibitors: an interview studyMargot Brinkhof, Sieta T de Vries, Peter G M Mol, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 18, 2024
[A rapidly enlarging neck mass]J F Lin, Thera P Links, K Esther Broekman, et al.
Investigational New Drugs|March 9, 2020
Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancerK Esther Broekman, Marieke A J Hof, Daan J Touw, et al.
BMJ Open|November 9, 2024
Factors affecting the feasibility of post-authorisation RCTs for conditionally authorised anticancer medicines: a multistakeholder perspective from a qualitative focus group studyChristine C van Hattem, Amos J de Jong, Jolien S de Groot, et al.
Drugs & Aging|December 20, 2023
Individualized Dosing Patterns in the Treatment of Older Patients with Gastrointestinal Stromal Tumors: Results of a Registry-Based Observational National Cohort Study Including 871 PatientsRoos F Bleckman, K Esther Broekman, Evelyne Roets, et al.
Clinical Pharmacokinetics|July 16, 2024
Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma CohortMarinda Meertens, Eline L Giraud, Maud B A van der Kleij, et al.
Pageof 1